Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

被引：0
|
作者：
M. Opdam
V. van der Noort
M. Kleijn
A. Glas
I. Mandjes
S. Kleiterp
F. S. Hilbers
D. T. Kruger
A. D. Bins
P. C. de Jong
P. P. J. B. M. Schiphorst
T. van Dalen
B. Flameling
R. C. Rietbroek
A. Beeker
S. M. van den Heiligenberg
S. D. Bakker
A. N. M. Wymenga
I. M. Oving
R. M. Bijlsma
P. J. van Diest
J. B. Vermorken
H. van Tinteren
S. C. Linn
机构：
[1] Netherlands Cancer Institute,Department of Molecular Pathology
[2] Netherlands Cancer Institute,Biometrics Department
[3] Agendia NV,Medical Affairs
[4] Amsterdam UMC,Department of Medical Oncology
[5] Sint-Antonius Hospital,Department of Medical Oncology
[6] Streekziekenhuis Koningin. Beatrix,Department of Internal Medicine
[7] Diakonessenhuis,Department of Surgery
[8] OLVG,Department of Medical Oncology
[9] Red Cross Hospital,Department of Internal Medicine
[10] Spaarne Gasthuis,Department of Medical Oncology
[11] Dijklander Ziekenhuis,Department of Medical Oncology
[12] Zaans Medisch Centrum,Department of Internal Medicine
[13] Medisch Spectrum Twente,Department of Medical Oncology
[14] Ziekenhuisgroep Twente,Department of Medical Oncology
[15] UMCU,Department of Medical Oncology
[16] UMCU,Department of Pathology
[17] University Hospital Antwerp (UZA),Department of Medical Oncology
[18] University of Antwerp,Faculty of Medicine and Health Sciences
[19] Trial and Data Center,Department of Medical Oncology
[20] Princess Maxima Centre for Pediatric Oncology,undefined
[21] Netherlands Cancer Institute,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 194卷
关键词：
Early breast cancer; Postmenopausal; MammaPrint 70-gene signature; Prognosis; Endocrine treatment; Overtreatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 278
页数：13
相关论文
共 50 条
  • [41] Comparing the 70-gene signature to the Dutch Breast Cancer guidelines in the prospective RASTER study
    Drukker, C. A.
    Bueno-de-Mesquita, J. M.
    Retel, V. P.
    Van Harten, W. H.
    Van Tinteren, H.
    Wesseling, J.
    Van 't Veer, L. J.
    Rutgers, E. J. T.
    Van de Vijver, M. J.
    Linn, S. C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S402 - S403
  • [42] Genomic risk classification by the 70-gene signature and 21-gene assay in African American early-stage breast cancer patients.
    Robinson, Patricia A.
    Tsai, Michaela L.
    Lo, Shelly S.
    Lee, June
    Socoteanu, Matei P.
    Kling, Heather
    Bolner, Michelle
    Blumencranz, Lisa Eileen
    Audeh, William
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study
    Noordhoek, Iris
    Bastiaannet, Esther
    de Glas, Nienke A.
    Scheepens, Josien
    Esserman, Laura J.
    Wesseling, Jelle
    Scholten, Astrid N.
    Schroder, Carolien P.
    Elias, Sjoerd G.
    Kroep, Judith R.
    Portielje, Johanneke E. A.
    Kleijn, Miranda
    Liefers, Gerrit-Jan
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (08) : 1172 - 1177
  • [44] Early determination of metastatic potential in breast cancer: The 70-gene signature in small tumors
    Knauer, M.
    Mook, S.
    ReteL, V.
    Kok, M.
    Wesseling, J.
    Glas, A. M.
    Rutgers, E. J.
    van 't Veer, L. J.
    Linn, S. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Prognostic value of "70-gene prognosis-signature" assay in early breast cancer
    Martinez-Ferez, I.
    Garcia-Estepa, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 178 - 178
  • [46] A new independent validation of the 70-gene signature in node-negative breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 131 - 131
  • [47] Impact of the 70-Gene Signature on Adjuvant Systemic Therapy Decisions in Early Breast Cancer Patients: Preliminary Results of a Prospective Multicenter Observational Study
    Kuijer, A.
    Straver, M.
    Elias, S. G.
    Smorenburg, C.
    Wesseling, J.
    Linn, S. C.
    Rutgers, E.
    Siesling, S.
    van Dalen, T.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S50 - S51
  • [48] Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
    Liefers, G. -J.
    Kranenbarg, E. Meershoek-Klein
    Carpentier, M. Duijm-de
    de Velde, C. J. van
    Kleijn, M.
    Dreezen, C.
    Menicucci, A.
    van't Veer, L.
    Audeh, W.
    BREAST, 2023, 68 : S21 - S21
  • [49] Can a 70-gene signature provide useful prognostic information in patients with node-negative breast cancer?
    Modlich, Olga
    Bojar, Hans
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (04): : 216 - 217
  • [50] Can a 70-gene signature provide useful prognostic information in patients with node-negative breast cancer?
    Olga Modlich
    Hans Bojar
    Nature Clinical Practice Oncology, 2007, 4 : 216 - 217
12345